A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects
NCT02650076
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Pruritus
Interventions
DRUG:
SK-1405
Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.